Related Experiment Video
Updated: Jun 20, 2026
07:03
Bilayer Microfluidic Device for Combinatorial Plug Production
Published on: December 1, 2023
Parallelized contactless microfluidic dispenser with superhydrophobic nozzles for scalable combinatorial screening.
Niphattha Wongwiset1, Morgan L Stephens2, Blanca I Quiñones-Díaz2
1Walker Department of Mechanical Engineering, the University of Texas at Austin, 10100 Burnet Road, 1.206 MER Bldg. 160, Austin, Texas, USA.
Biomicrofluidics
|June 19, 2026
Summary
We developed a novel parallel combinatorial microfluidic (PCM) system for rapid, cost-effective drug discovery. This high-throughput technology generates combinatorial maps quickly, enabling efficient cell-based assays and antibiotic screening.
Area of Science:
- Biotechnology
- Microfluidics
- Drug Discovery
Background:
- High-throughput combinatorial sample generation is vital for drug discovery and cell-based assays.
- Current methods face limitations in time and cost-effectiveness due to manual or serial-dispensing approaches.
Purpose of the Study:
- To introduce a novel parallel combinatorial microfluidic (PCM) system.
- To address the limitations of conventional methods for combinatorial sample generation.
Main Methods:
- Utilized hydraulic-resistance networks for simultaneous combinatorial map generation.
- Integrated superhydrophobic outlets for parallel contactless dispensing, minimizing contamination and processing time.
- Validated the system with devices for multiple combinatorial maps and droplet sizes of 3.5 μL.
Main Results:
- The PCM system completed all processes within 5 minutes, demonstrating rapid operation.
- Achieved high-throughput scalability and reliable production of predefined combinatorial maps.
- Proof-of-concept antibiotic cell assays showed biocompatibility and comparable results to standard methods (overlapping IC50 ranges).
Conclusions:
- The PCM system offers a novel, cost-effective, high-throughput technology for combinatorial screenings.
- The technology is suitable for drug development and cell-based assays.
- Future improvements targeting smaller droplet sizes (sub-3.5 μL) are expected to enhance accuracy.
